Why NIO Stock Is Trading Lower Today

NIO Inc – ADR (NYSE: NIO) shares are trading lower by 1.22% to $9.28 Tuesday afternoon. Shares of several Chinese stocks are trading lower after China's central bank made cuts to its one-year loan prime rate and five-year rate amid attempts to stimulate the

NIO Inc – ADR (NYSE:NIO) shares are trading lower by 1.22% to $9.28 Tuesday afternoon. Shares of several Chinese stocks are trading lower after China’s central bank made cuts to its one-year loan prime rate and five-year rate amid attempts to stimulate the country’s economic recovery.

According to Reuters, China has implemented its first reduction in key lending benchmarks in 10 months. The move aims to support a decelerating economic recovery. However, due to concerns regarding the property market, the easing measures were not as extensive as anticipated.

See Also: What’s Going On With Ford Shares

Per Reuters, the one-year loan prime rate (LPR) was decreased by 10 basis points to 3.55%, while the five-year LPR saw a similar reduction to 4.20%. This monetary loosening occurs as China experiences a slowdown in the initial momentum observed during the first quarter.

According to data from Benzinga Pro, NIO has a 52-week high of $24.43 and a 52-week low of $7.00.

Total
0
Shares
Related Posts
Read More

5 On-The-Money Stock Picks From Benzinga’s Most Accurate Analysts

Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes to one single stock, analyst ratings and price targets can vary widely, leaving investors confused about which analyst's opinion to trust.

CHRA

Read More

2 High-Yielding Dividend ETFs That May Help Diversify Your Investment Strategy

Hunting for the perfect dividend stocks for your portfolio can be a challenging aspect of diversification. An easy way to mitigate these issues is by purchasing an exchange-traded fund (ETF) that invests in high-yielding stocks that fit your strategy. The pros of investing in a dividend ETF:

ARR

Read More

Reported Late Monday, MediciNova Receives A Notice Of Allowance For A New Patent Covering MN-001 And MN-002 For The Treatment Of Hypertriglyceridemia, Hypercholesterolemia, and Hyperlipoproteinemia In Brazil

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced it has received a Notice of Allowance

MNOV